[go: up one dir, main page]

IE38423B1 - Vaccine for nenatal calf diarrhea - Google Patents

Vaccine for nenatal calf diarrhea

Info

Publication number
IE38423B1
IE38423B1 IE1925/73A IE192573A IE38423B1 IE 38423 B1 IE38423 B1 IE 38423B1 IE 1925/73 A IE1925/73 A IE 1925/73A IE 192573 A IE192573 A IE 192573A IE 38423 B1 IE38423 B1 IE 38423B1
Authority
IE
Ireland
Prior art keywords
vaccine
calf diarrhea
diarrhea
nenatal
bovine
Prior art date
Application number
IE1925/73A
Other versions
IE38423L (en
Original Assignee
Univ Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nebraska filed Critical Univ Nebraska
Publication of IE38423L publication Critical patent/IE38423L/en
Publication of IE38423B1 publication Critical patent/IE38423B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

1401565 Calf diarrhea vaccine UNIVERSITY OF NEBRASKA REGENTS OF 23 Oct 1973 [30 Oct 1972] 49253/73 Heading A5B A calf diarrhea vaccine comprises an attenuated or inactivated coronavirus-like calf diarrhea virus. The vaccine may be in the form of a combination vaccine comprising inactivated coronavirus and reovirus, both of which are prepared by inactivating a live virus, either unaaatenuated or attenuated, by chamicals, radiation or heat. Coronavirus can also be combined with bovine adenovirus, bovine virus diarrhea, or other bovine pathogens such as E. Coli or clostridia sp. [GB1401565A]
IE1925/73A 1972-10-30 1973-10-26 Vaccine for nenatal calf diarrhea IE38423B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30217972A 1972-10-30 1972-10-30

Publications (2)

Publication Number Publication Date
IE38423L IE38423L (en) 1974-04-30
IE38423B1 true IE38423B1 (en) 1978-03-15

Family

ID=23166611

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1925/73A IE38423B1 (en) 1972-10-30 1973-10-26 Vaccine for nenatal calf diarrhea

Country Status (17)

Country Link
JP (3) JPS5817169B2 (en)
AR (1) AR200155A1 (en)
AU (1) AU476160B2 (en)
BE (1) BE806568A (en)
CA (1) CA1019675A (en)
CH (1) CH596315A5 (en)
DD (1) DD110517A5 (en)
DE (1) DE2354324C2 (en)
ES (1) ES419996A1 (en)
FI (1) FI52740C (en)
FR (1) FR2204405B1 (en)
GB (1) GB1401565A (en)
HU (1) HU168486B (en)
IE (1) IE38423B1 (en)
NL (1) NL7314293A (en)
SE (1) SE419500B (en)
ZA (1) ZA738329B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027007U (en) * 1983-07-30 1985-02-23 株式会社　協立双葉自動機 Labeling machine with container rotation speed adjustment device
JPH0518338Y2 (en) * 1985-12-27 1993-05-17
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine
GB8818415D0 (en) * 1988-08-03 1988-09-07 Animal Health Inst Vaccine
JPH08786B2 (en) * 1993-02-25 1996-01-10 株式会社微生物化学研究所 Bovine coronavirus infectious disease vaccine
WO2017077804A1 (en) 2015-11-06 2017-05-11 旭化成メディカル株式会社 Method for producing parvovirus having high infectivity titer and high purity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759425A (en) * 1969-11-28 1971-05-25 Mebus Charles A CALVES DIARRHEA VACCINES, THEIR PREPARATION AND USE
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same

Also Published As

Publication number Publication date
FI52740C (en) 1977-11-10
FR2204405B1 (en) 1977-01-28
DE2354324A1 (en) 1974-05-09
CA1019675A (en) 1977-10-25
NL7314293A (en) 1974-05-02
GB1401565A (en) 1975-07-16
JPS5757449B2 (en) 1982-12-04
FR2204405A1 (en) 1974-05-24
AU6177473A (en) 1975-04-24
JPS5531058A (en) 1980-03-05
JPS6124370B2 (en) 1986-06-10
HU168486B (en) 1976-05-28
JPS4980230A (en) 1974-08-02
ZA738329B (en) 1974-09-25
AR200155A1 (en) 1974-10-24
JPS5817169B2 (en) 1983-04-05
JPS57131726A (en) 1982-08-14
AU476160B2 (en) 1976-09-16
FI52740B (en) 1977-08-01
DE2354324C2 (en) 1982-06-03
DD110517A5 (en) 1974-12-20
ES419996A1 (en) 1976-08-01
CH596315A5 (en) 1978-03-15
SE419500B (en) 1981-08-10
BE806568A (en) 1974-04-26
IE38423L (en) 1974-04-30

Similar Documents

Publication Publication Date Title
ES2179105T3 (en) PROTEIN ASSISTANTS.
ATE410183T1 (en) IMPROVED SAPONIN-BASED ADJUVANT COMPOSITIONS AND RELATED METHODS
ATE219948T1 (en) RECOMBINANT VACCINES THAT CONTAIN IMMUNOGENE ATTENUATE RPOS-POSITIVE PHENTOTYPE BACTERIA
ES254659U (en) Deformable light-weight housing structure
DE69322092D1 (en) NEW BACTERIAL VACCINES USING VACCINE STRAINS FROM PATHOGENIC BACTERIA
NO912825D0 (en) PROCEDURE FOR THE PREPARATION OF COCONJUGATE VACCINES INCLUDING IMMUNOGENIC PROTEIN, HIV RELATED PEPTIDES AND ANIONIC GROUPS.
NZ314585A (en) Method of treating H. Pylori associated gastroduodenal disease
IE38423B1 (en) Vaccine for nenatal calf diarrhea
DK103412C (en) Method for stabilizing biologically active bacteria, bacterial metabolic products, viruses, sera and enzymes.
IT1044555B (en) Benzodipyrones - used for treatment of allergic asthma
TW340873B (en) Chicken anaemia agent vaccine
CA961410A (en) Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
DE3064768D1 (en) ANTICOLIBACILLARY ANIMAL VACCINE, PREPARATION, APPLICATION AND USED ESCHERICHIA COLI STRAINS
ES2076330T3 (en) FILM FOR AGRICULTURAL USE.
CA983851A (en) Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same
ATE16348T1 (en) OZONE-INACTIVATED GERMS AS VACCINE.
NL300073I1 (en) Vaccine.
IT8020442A0 (en) PROCEDURE, USE THEREOF AND DEVICE FOR HANDLING PRINTED PRODUCTS.
GB1036621A (en) Improvements in or relating to bacterial vaccines
SE7711433L (en) TRICYCLIC ASSOCIATIONS
SU565653A1 (en) Method of preservation of bone tissue
JPS5213146A (en) Infrared ray radiator
GB949400A (en) Poliomyelitis vaccines
before Parliament et al. The Industrial Relations (Code of Practice) Order 1972
JPS5359023A (en) Inactivation of toxins produced by microbials and attenuation of vaccines